ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is Coconut Oil Healthy? (The American Heart Association Doesn’t Think So)

American Heart Association Renders Itself Obsolete With 1960s Dietary Advice on Coconut Oil

How Fish Oil Benefits Heart Disease Patients with Depression

Ginger Fights Obesity

Health Benefits of Artichokes

Putting the Spotlight on Coriander Seed Oil

Migraines? Powdered Ginger May Help

Are Americans Really Getting Too Much Vitamin D? A Critical Look at Recent Media Warnings

Eating more vegetable protein may protect against early menopause

Vitamin C and antibiotics: A new one-two 'punch' for knocking-out cancer stem cells

Print Page
Email Article

Michigan Trial of Acupuncture Effect on FM Pain Now Recruiting

  [ 355 votes ]   [ Discuss This Article ] • January 24, 2007

A study to investigate the mechanisms by which acupuncture might relieve pain due to Fibromyalgia is recruiting diagnosed adult female FM patients who suffer pain at least 50 percent of days; have not previously undergone acupuncture therapy; and are located within about 1 - !/2 hours’ traveling distance of Ann Arbor, Michigan.

The study ( number NCT00142597) is being conducted by researchers at the University of Michigan’s Chronic Pain and Fatigue Research Center and is sponsored the National Center for Complementary and Alternative Medicine (NCCAM). Its objective: to “Determine the effectiveness of acupuncture versus a placebo [simulated acupuncture] in altering brain activity and relieving pain due to Fibromyalgia” – and possibly “lead to acupuncture’s acceptance by the Western medical and scientific communities as a practical treatment option.”

Study details, basic eligibility guidelines, specifics of the multiple inclusion & exclusion criteria, and contact information for interested patients are as follows.

Study Objectives & Design

As the investigators, led by Principal Investigator Richard E. Harris, PhD, explain it:
n Acupuncture functions by targeting specific nerve pathways to different organs or parts of the body. Research has shown that acupuncture is effective in decreasing or eliminating people’s sensitivity to pain in targeted regions.
n However, some believe that the reduction in pain is due to a placebo response rather than acupuncture itself. This study will use two brain-imaging techniques to determine the brain response to acupuncture versus a simulation of acupuncture, thereby assessing whether acupuncture is actually effective in relieving pain.
n Participants in this single-blind study will be randomly assigned to receive either acupuncture or placebo. The placebo will consist of a simulation of acupuncture, performed with a toothpick.
n Functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) will be used to assess activity of the mu-opioid receptors. These receptors are located in the brain and are involved in the body’s ability to perceive pain. All participants will be scanned using the fMRI scanner. Only those participants who meet certain inclusion criteria will also receive a PET scan.
n Participants who do qualify, however, may elect not to receive a PET scan. Participants’ assigned treatments will be performed while they are inside the scanner.
n Baseline measures during the initial fMRI session will involve applying pressure to the thumb to elicit a pain response in the brain and assessing the corresponding fMRI blood oxygen level dependent (BOLD) signal.
n Participants will then receive 9 treatments of acupuncture or placebo outside the scanner over a 4-week period. The final session will be performed in the fMRI scanner to assess changes in the BOLD signal over the 4 weeks.
n During the first session in the PET scanner, baseline measurements will determine brain activity prior to the intervention. Participants will then receive their assigned treatments while in the scanner.
n After this first session, participants will have 7 additional treatment sessions outside of the scanner over a 4-week period.
n The last session will be performed in the scanner to assess changes in mu-opioid receptor activity that may have occurred over the 4 weeks.”

Eligibility Guidelines
Female FM patients between the ages of 18 and 75 may be eligible to participate in this study.

Inclusion Criteria for fMRI
1. Has met American College of Rheumatology (1990) criteria for the diagnosis of Fibromyalgia for at least 1 year
2. Chronic pain more than 50% of days
3. Willing to limit introduction of any new medications or treatments for fibromyalgia during the study
4. Able to attend study visits up to three times weekly
5. Right-handed

Inclusion Criteria for PET
1. Meets fMRI inclusion criteria
2. Willing to refrain from alcohol intake for 48 hours prior to PET studies

Exclusion Criteria for fMRI
Factors that will rule out participation include:
1. Knowledge that could prevent "blinding" of the participant to the study interventions (including previous acupuncture treatment)
2. Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis that may preclude the safe use of acupuncture
3. Autoimmune or inflammatory disease (in addition to fibromyalgia) that causes pain (e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease)
4. Daily use of narcotic pain-relievers
5. History of substance abuse
6. Simultaneous participation in other therapeutic trials
7. Pregnant or breastfeeding
8. Current severe psychiatric illness (e.g., schizophrenia, major depression with suicidal ideation)
9. Condition that may make exposure to fMRI medically inadvisable
10. Any condition that may prevent satisfactory completion of the study protocol

Exclusion Criteria for PET
Factors that will rule out participation include:
1. Meets any of the fMRI exclusion criteria
2. Current major depression
3. Condition that may make exposure to PET medically inadvisable.

Contact Information & Location
Contact Ginny Leone at 734-998-7110 or e-mail
Please refer to this study by identifier NCT00142597

Study ID Numbers: K01 AT01111-01; 1-K01-AT01111-01
Health Authority: United States: Federal Government

Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra EPA  - Fish Oil Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

NAD+ Ignite with Niagen

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Complete and Natural Menopause Relief Complete and Natural Menopause Relief
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine
Breakthrough Form of Magnesium Enhances Memory and Cognitive Function Breakthrough Form of Magnesium Enhances Memory and Cognitive Function
Bone Broth Benefits for Digestion, Arthritis and Cellulite Bone Broth Benefits for Digestion, Arthritis and Cellulite
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map